Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation. | Front Immunol | 2023 | 38274824 | PubTator, text mining | PubMed |
| Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. | Pathogens | 2023 | 38251321 | PubTator, text mining | PubMed |
| NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens. | Front Immunol | 2023 | 38235131 | PubTator, text mining | PubMed |
| Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay. | Front Immunol | 2023 | 38187380 | PubTator, text mining | PubMed |
| Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. | Front Immunol | 2023 | 38179040 | PubTator, text mining | PubMed |
| LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells. | Front Immunol | 2023 | 38169736 | PubTator, text mining | PubMed |
| An impaired ubiquitin-proteasome system increases APOBEC3A abundance. | NAR Cancer | 2023 | 38155930 | PubTator, text mining | PubMed |
| Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α. | Int J Mol Sci | 2023 | 38138998 | PubTator, text mining | PubMed |
| Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections. | Cancers (Basel) | 2023 | 38136285 | PubTator, text mining | PubMed |
| Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis. | Pathogens | 2023 | 38133265 | PubTator, text mining | PubMed |
| Proteomic Analysis of Human iPSC-Derived Neural Stem Cells and Motor Neurons Identifies Proteasome Structural Alterations. | Cells | 2023 | 38132120 | PubTator, text mining | PubMed |
| A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. | Sci Rep | 2023 | 38086949 | PubTator, text mining | PubMed |
| Therapeutic cancer vaccines: advancements, challenges, and prospects. | Signal Transduct Target Ther | 2023 | 38086815 | PubTator, text mining | PubMed |
| An Overview on Antimalarial Peptides: Natural Sources, Synthetic Methodology and Biological Properties. | Molecules | 2023 | 38067508 | PubTator, text mining | PubMed |
| Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success. | Cancers (Basel) | 2023 | 38067396 | PubTator, text mining | PubMed |
| Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. | Cancers (Basel) | 2023 | 38067336 | PubTator, text mining | PubMed |
| Oral Bacteria, Virus and Fungi in Saliva and Tissue Samples from Adult Subjects with Oral Squamous Cell Carcinoma: An Umbrella Review. | Cancers (Basel) | 2023 | 38067244 | PubTator, text mining | PubMed |
| Association between prior-night sleep and next-day fatigue in older adults: a daily diary study. | BMC Geriatr | 2023 | 38062384 | PubTator, text mining | PubMed |
| An Ancestral Major Histocompatibility Complex Organization in Cartilaginous Fish: Reconstructing MHC Origin and Evolution. | Mol Biol Evol | 2023 | 38059517 | PubTator, text mining | PubMed |
| Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. | Mol Cancer | 2023 | 38049829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=10